Wang Chen
China-Japan Friendship Hospital · Respiratory and Critical Care · Beijing
PVRI) 、 、ClinicalRespiratoryJournal 、ChineseMedicalJournal 、 、.:.:1985,1991.1994.:1985 8 2010 8, 、 、;2010 8 2013 1,;2013 1 2014 9,;2014 9 2018 1,;2018 1,;2018 5,. (:1994.01-1995.01 ): 、863、973 、.: 2008-2010, (2006BAI01A06),,516 2010-2013, (201002008),,2834 2011-2014, H1N1 (81030032),,230 2012-2015, (2012BAI05B00),,1370 2015-2018, (81430001),,320 2016-2020, 、 (2016YFC1303900),,725 2021-2025, (82090010),,1791.7: 《NewEnglandJournalofMedicine》、《Lancet》,: 1.HeZ,RenL,YangJ,GuoL,FengL,MaC,WangX,LengZ,TongX,ZhouW,WangG,ZhangT,GuoY,WuC,WangQ,LiuM,WangC,JiaM,HuX,WangY,ZhangX,HuR,ZhongJ,YangJ,DaiJ,ChenL,ZhouX,WangJ,YangW,WangC.Seroprevalenceandhumoralimmunedurabilityofanti-SARS-CoV-2antibodiesinWuhan,China:alongitudinal,population-level,cross-sectionalstudy.Lancet.2021Mar20;397(10279):1075-1084. 2.HeZ,RenL,YangJ,GuoL,FengL,MaC,WangX,LengZ,TongX,ZhouW,WangG,ZhangT,GuoY,WuC,WangQ,LiuM,WangC,JiaM,HuX,WangY,ZhangX,HuR,ZhongJ,YangJ,DaiJ,ChenL,ZhouX,WangJ,YangW,WangC.Seroprevalenceandhumoralimmunedurabilityofanti-SARS-CoV-2antibodiesinWuhan,China:alongitudinal,population-level,cross-sectionalstudy.Lancet.2021Mar20;397(10279):1075-1084. 3.XiaoD,Chen,ZM,WuSN,HuangKW,XuJY,YangL,XuYJ,ZhangXY,BaiCX,KangJ,RanPX,ShenHH,Wen,FQ,YaoWZ,SunTY,ShanGL,YangT,LinYX,ZhuJG,WangRY,ShiZH,ZhaoJP,YeXW,SongYL,WangQY,HouG,ZhouYM,LiW,DingLR,WangH,ChenYH,GuoYF,XiaoF,LuY,PengXX,ZhangB,WangZM,ZhangH,BuXN,ZhangXL,AnL,ZhangS,CaoZX,ZhanQY,YangYH,LiangLR,LiuZ,ZhangXR,ChengAQ,CaoB,DaiHP,ChungKF,HeJ,WangC;ChinaPulmonaryHealth(CPH)StudyGroup.Prevalenceandriskfactorsofsmallairwaydysfunction,andassociationwithsmoking,inChina:findingsfromanationalcross-sectionalstudy.LancetRespirMed.2020Nov1;8(11):1081-93. 4.WangY,ZhangD,DuG,DuR,ZhaoJ,JinY,FuS,GaoL,ChengZ,LuQ,HuY,LuoG,WangK,LuY,LiH,WangS,RuanS,YangC,MeiC,WangY,DingD,WuF,TangX,YeX,YeY,LiuB,YangJ,YinW,WangA,FanG,ZhouF,LiuZ,GuX,XuJ,ShangL,ZhangY,CaoL,GuoT,WanY,QinH,JiangY,JakiT,HaydenFG,HorbyPW,CaoB,WangC.RemdesivirinadultswithsevereCOVID-19:arandomised,double-blind,placebo-controlled,multicentretrial.Lancet.2020May16;395(10236):1569-1578. 5.ChenS,ZhangZ,YangJ,WangJ,ZhaiX,BärnighausenT,WangC.Fangcangshelterhospitals:anovelconceptforrespondingtopublichealthemergencies.Lancet.2020Apr18;395(10232):1305-1314. 6.WangC,HorbyPW,HaydenFG,GaoGF.Anovelcoronavirusoutbreakofglobalhealthconcern.Lancet.2020Feb15;395(10223):470-473. 7.WangC,ChenS,ZhuJ,LiW.China'snew4+4medicaleducationprogramme.Lancet.2019Sep28;394(10204):1121-1123. 8.HuangK,YangT,XuJ,YangL,ZhaoJ,ZhangX,BaiC,KangJ,RanP,ShenH,WenF,ChenY,SunT,ShanG,LinY,XuG,WuS,WangC,WangR,ShiZ,XuY,YeX,SongY,WangQ,ZhouY,LiW,DingL,WanC,YaoW,GuoY,XiaoF,LuY,PengX,ZhangB,XiaoD,WangZ,ChenZ,BuX,ZhangH,ZhangX,AnL,ZhangS,ZhuJ,CaoZ,ZhanQ,YangY,LiangL,TongX,DaiH,CaoB,WuT,ChungKF,HeJ,WangC;ChinaPulmonaryHealth(CPH)StudyGroup.Prevalence,riskfactors,andmanagementofasthmainChina:anationalcross-sectionalstudy.Lancet.2019Aug3;394(10196):407-418. 9.WangC,ZhaiX,ZhangX,LiL,WangJ,LiuDP;ChineseAcademyofMedicalSciences.Gene-editedbabies:ChineseAcademyofMedicalSciences'responseandaction.Lancet.2019Jan5;393(10166):25-26. 10.WangC,XuJ,YangL,XuY,ZhangX,BaiC,KangJ,RanP,ShenH,WenF,HuangK,YaoW,SunT,ShanG,YangT,LinY,WuS,ZhuJ,WangR,ShiZ,ZhaoJ,YeX,SongY,WangQ,ZhouY,DingL,YangT,ChenY,GuoY,XiaoF,LuY,PengX,ZhangB,XiaoD,ChenCS,WangZ,ZhangH,BuX,ZhangX,AnL,ZhangS,CaoZ,ZhanQ,YangY,CaoB,DaiH,LiangL,HeJ;ChinaPulmonaryHealthStudyGroup.PrevalenceandriskfactorsofchronicobstructivepulmonarydiseaseinChina(theChinaPulmonaryHealth[CPH]study):anationalcross-sectionalstudy.Lancet.2018Apr28;391(10131):1706-1717. 11.XiaoD,BaiCX,ChenZM,WangC.ImplementationoftheWorldHealthOrganizationFrameworkConventiononTobaccoControlinChina:Anarduousandlong-termtask.Cancer.2015Sep1;121Suppl17:3061-8. 12.QiaoR,RosenMJ,ChenR,WuS,MarciniukD,WangC;CTS-ACCPPulmonaryandCriticalCareMedicineWorkgroup.EstablishingpulmonaryandcriticalcaremedicineasasubspecialtyinChina:jointstatementoftheChinesethoracicsocietyandtheAmericancollegeofchestphysicians.Chest.2014Jan;145(1):27-29. 13.WangC,LiuQ.AturningpointforclinicalresearchinChina?Lancet.2013Sep7;382(9895):835-6. 14.ZhanQ,SunB,LiangL,YanX,ZhangL,YangJ,WangL,MaZ,ShiL,WeiL,LiG,YangL,ShiZ,ChenY,XuQ,LiW,ZhuX,WangZ,SunY,ZhuoJ,LiuY,LiX,WangC.Earlyuseofnoninvasivepositivepressureventilationforacutelunginjury:amulticenterrandomizedcontrolledtrial.CritCareMed.2012Feb;40(2):455-60. 15.WangC,CaoB,LiuQQ,ZouZQ,LiangZA,GuL,DongJP,LiangLR,LiXW,HuK,HeXS,SunYH,AnY,YangT,CaoZX,GuoYM,WenXM,WangYG,LiuYL,JiangLD.OseltamivircomparedwiththeChinesetraditionaltherapymaxingshigan-yinqiaosaninthetreatmentofH1N1influenza:arandomizedtrial.AnnInternMed.2011Aug16;155(4):217-25. 16.WangC,ZhaiZ,YangY,WuQ,ChengZ,LiangL,DaiH,HuangK,LuW,ZhangZ,ChengX,ShenYH;ChinaVenousThromboembolism(VTE)StudyGroup.Efficacyandsafetyoflowdoserecombinanttissue-typeplasminogenactivatorforthetreatmentofacutepulmonarythromboembolism:arandomized,multicenter,controlledtrial.Chest.2010Feb;137(2):254-62. 17.CaoB,LiXW,MaoY,WangJ,LuHZ,ChenYS,LiangZA,LiangL,ZhangSJ,ZhangB,GuL,LuLH,WangDY,WangC;NationalInfluenzaAPandemic(H1N1)2009ClinicalInvestigationGroupofChina.Clinicalfeaturesoftheinitialcasesof2009pandemicinfluenzaA(H1N1)virusinfectioninChina.NEnglJMed.2009Dec24;361(26):2507-17.: 、 、 、 、,.::,2006, (SARS),,2008,,,2009,,,2014, 2009 H1N1,,2017, H7N9,.
No data yet